Leading Infectious Disease Biomaterial Manufacturer

  • Copan FLOQSwab® and Liquid Control Products
    • Clinical Diagnostics,
    • Proficiency Programs,
    • Training, Verification and Development
  • Antigens for Diagnostic Test Manufacturers
  • Viral Transport Medium – DxTM™
VTM? – LEARN MORE

Microbix Achieves Further QAPs Sales Record

Over C$ 1 Million in One Shipment to a Leading Lab Accreditation Agency MISSISSAUGA, CANADA, January 3, 2024 – Microbix Biosystems Inc. (TSX: MBX,...
Read More

Microbix Reports Results for Q4 & Full-Year Fiscal 2023

Full-Year Sales of $16.5 million and Net Loss of $0.04 million MISSISSAUGA, CANADA, December 21, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Read More

Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy

Expanded Collaboration to Improve Syndromic Infectious Disease Testing MISSISSAUGA, CANADA & IRVINE, CALIFORNIA, December 14, 2023 – Microbix...
Read More

QAPS

Why choose Microbix Quality Assessment Products (QAPs)? Find out more.

INFECTIOUS DISEASE ANTIGENS

Microbix produces one of the world’s broadest range of infectious disease antigens.

PARTNERSHIP OPPORTUNITIES

Microbix has a partnership opportunity. Check it out here.

Our Commitment to Quality

Our quality process ensures our customers receive products that meet and exceed their needs and expectations. Our quality management system takes into consideration regulatory requirements that are applicable to the type of products we manufacture and the industries we serve.

               
  INVESTORS
 LEGAL
 CONTACT BLOG DOWNLOAD CATALOGUE